Publikation bearbeiten
nab-Paclitaxel at a dose of 125 mg/m(2) weekly is more efficacious but less toxic than at 150 mg/m(2). Results from the neoadjuvant randomized GeparSepto study (GBG 69)
(
Zeitschriftenartikel
)